View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Aileron Therapeutics Reports First Quarter 2024 Financial Results and ...

Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated Topline results from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) expected in the third quarter of 2024 AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron” or the “Company”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class med...

 PRESS RELEASE

Molecular Templates, Inc. Reports First Quarter 2024 Financial Result...

Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action, today reported financial results and business updates for the first quarter of 2024. Recent Company Highlights MTEM presented clinical d...

 PRESS RELEASE

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position

CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position Expanding Relationship With Lifera, a Biopharma Company Owned by the PIF CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced it has entered into a set of agreements with Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) in Saudi Arabia. The expanded relationship, which takes the form of a $15 million purchase of ...

ABGSC Seafood Research ... (+3)
  • ABGSC Seafood Research
  • Martin Kaland
  • Simon Brun

Strong start to the comeback year

'24e EBIT (core) +2% due to Austral and Br. Birkeland. Attractive exposure to fishmeal and fish oil industries. 9% dividend yield and 20% upside to TP of NOK 114: BUY

ABGSC Seafood Research ... (+3)
  • ABGSC Seafood Research
  • Martin Kaland
  • Simon Brun

Looks increasingly worth the wait

'24e-'25e EBIT (core) largely unchanged post Q1. Investments gradually translating into better operations. '24e-'25e P/E 12x-10x; BUY reiterated, TP of NOK 65.

 PRESS RELEASE

Mobivity Announces First Quarter 2024 Financial Results

Mobivity Announces First Quarter 2024 Financial Results PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Mobivity Holdings Corp. (OTCQB: MFON), a provider of technology connecting mobile gaming audiences to real-world brands and products, today announced financial results for the first quarter (“Q1”) ending March 31, 2024. Recent Business Highlights Grew consumer audience by more than 30% to over nine million consumers vs Q4 2023Added 6 new brand partners including leaders in fuel and convenience and fast casual restaurants in Q1 2024Increased conversion rate of audiences by 15% vs Q4 2023...

 PRESS RELEASE

Extendicare Announces 2024 First Quarter Results

Extendicare Announces 2024 First Quarter Results MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are presented in Canadian dollars unless otherwise noted. First Quarter 2024 Highlights Adjusted EBITDA(1) excluding one-time items improved by $8.0 million to $20.3 million, largely driven by home health care volume growth, rate increases and growth in managed services.Home health care growth continued, with Q1 average daily volume (“ADV”) increasing to 2...

 PRESS RELEASE

HP Inc. Declares Dividend

HP Inc. Declares Dividend PALO ALTO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2756 per share on the company’s common stock. The dividend, the third in HP’s fiscal year 2024, is payable on July 3, 2024, to stockholders of record as of the close of business on June 12, 2024. HP has approximately 1.0 billion shares of common stock outstanding. About HP Inc. HP Inc. (NYSE: HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operati...

 PRESS RELEASE

EPR Properties Declares Monthly Dividend for Common Shareholders

KANSAS CITY, Mo.--(BUSINESS WIRE)-- EPR Properties (NYSE:EPR) today announced that its Board of Trustees has declared its monthly cash dividend to common shareholders. The dividend of $0.285 per common share is payable June 17, 2024 to shareholders of record on May 31, 2024. This dividend represents an annualized dividend of $3.42 per common share. About EPR Properties EPR Properties (NYSE:EPR) is the leading diversified experiential net lease real estate investment trust (REIT), specializing in select enduring experiential properties in the real estate industry. We focus on real estate ve...

 PRESS RELEASE

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) --  Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,500 shares of its common stock to five new employees, consisting of inducement stock options to purchase an aggregate of 25,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 26,500 shares of its common stock. These inducem...

 PRESS RELEASE

Element Announces Annual Meeting Voting Results

Element Announces Annual Meeting Voting Results TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Element Fleet Management Corp. (TSX:EFN) (“Element” or the “Company”), the largest publicly traded, pure-play automotive fleet manager in the world, confirmed today that all ten nominees listed in its management information circular dated April 1, 2024 were elected as directors at the Annual Meeting of Shareholders held on May 15, 2024 (the “Meeting”), with each director receiving strong support as demonstrated by the results below. A total of 338,248,770 common shares (approximately 86.96% of the ou...

 PRESS RELEASE

Farmers & Merchants Bancorp (FMCB) Increases Cash Dividend for the 59t...

Farmers & Merchants Bancorp (FMCB) Increases Cash Dividend for the 59th Consecutive Year LODI, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp (OTCQX: FMCB) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California (the “Bank” or “F&M Bank”), the Board of Directors declared a mid-year cash dividend of $8.80 per share, an increase of 6.0% over the $8.30 per share paid in July of 2023. The cash dividend is payable on July 1, 2024, to shareholders of record on June 11, 2024. The Company’s trailing twelve months net income through the...

 PRESS RELEASE

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's principal regulator, the British...

 PRESS RELEASE

Outlook Therapeutics® Reports Financial Results for Second Quarter Fis...

Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA™ (bevacizumab gamma)United Kingdom (UK) Marketing Authorization Application (MAA) submitted NORSE EIGHT fully underway in the US; Topline readout expected in Q4 CY2024Resubmission of the ONS-5010 Biologics License Application (BLA) planned by the end of CY2024 Company to host inaugural quarterly update conference call and webcast on Th...

 PRESS RELEASE

Peyto Exploration & Development Corp. Confirms Monthly Dividend for Ju...

Peyto Exploration & Development Corp. Confirms Monthly Dividend for June 14, 2024 CALGARY, Alberta, May 15, 2024 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto") confirms that the monthly dividend with respect to May 2024 of $0.11 per common share is to be paid on June 14, 2024, for shareholders of record on May 31, 2024. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at to learn more about what makes Peyto one of North Am...

 PRESS RELEASE

Profound Medical Annual General Meeting of Shareholders Voting Results

Profound Medical Annual General Meeting of Shareholders Voting Results TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total of 15,336,388 common shares, representing 62.78% of the common shares outstanding, were represented in person and by proxy at the Meeting. All of the matters put forward before the shareholders, as set out in the Company’s management information circular dated April 5...

 PRESS RELEASE

GT Biopharma Reports First Quarter 2024 Financial Results and Provides...

GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update IND clearance for GTB-3650, a 2nd generation nanobody TriKE® for treatment of CD33+ leukemia expected in Q2 2024Phase 1 trial initiation with GTB-3650 expected in 2H 2024Anticipate IND submission for GTB-5550 TriKE® for treatment of B7H3 positive solid tumors in Q4 2024Plan to initiate a Phase 1 dose escalation basket trial evaluating GTB-5550 in six solid tumor cancers – prostate, breast, head and neck, ovarian, lung, and GICash of approximately $9.81 million as of March 31, 2024, provides sufficient ru...

 PRESS RELEASE

AGBA Solidifies Market Leadership with Expansion Plans and Focus on Te...

AGBA Solidifies Market Leadership with Expansion Plans and Focus on Tech/Fintech Innovation LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or the “Company” or the “Group”), the leading one-stop financial supermarket in Hong Kong released its financial results for the first quarter of 2024.   AGBA is thrilled to unveil its expansion plans, including the planned acquisition of Triller in the U.S. and the completion of the acquisition of Sony Life in Singapore. The Company is in the acquisition process with Triller and eagerly anticipates a...

 PRESS RELEASE

ROHM at PCIM Europe 2024: Empowering Growth, Inspiring Innovation

ROHM at PCIM Europe 2024: Empowering Growth, Inspiring Innovation Showcasing highly efficient EcoGaN™ and SiC power solutions Santa Clara, CA and Kyoto, Japan, May 15, 2024 (GLOBE NEWSWIRE) -- today announced they will present new power semiconductor solutions, with a special focus on wide bandgap devices, at this year’s PCIM Europe – the leading trade fair for power electronics in Nuremberg, Germany (June 11 – 13). Visit ROHM in Booth 304, Hall 9. ROHM’s SiC, Si and GaN portfolio is designed to fulfill the needs of various sectors, focusing on e-mobility and power supply applicatio...

 PRESS RELEASE

TC Energy to appeal Delaware court rulings in lawsuit related to 2016 ...

TC Energy to appeal Delaware court rulings in lawsuit related to 2016 Columbia Pipeline acquisition CALGARY, Alberta, May 15, 2024 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) strongly disagrees with the final decision issued today by the Delaware Chancery Court (the “Court”) allocating liability for earlier determined damages in an ongoing class action lawsuit related to TC Energy’s 2016 acquisition of Columbia Pipeline Group Inc. ("Columbia"). The Court previously held, in a decision issued in June 2023, that the former CEO and CFO...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch